[{"AccountsPayableCurrent_0_Q2_USD":2476000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":38581000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":90826000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":12010000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":157000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":78565000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":89000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":40000.0,"OtherNoncashIncomeExpense_2_Q2_USD":0.0,"OtherLiabilitiesCurrent_0_Q2_USD":34000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-7000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":1000.0,"OtherAssetsNoncurrent_0_Q2_USD":3597000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":427000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":13403000.0,"OperatingLeasePayments_2_Q2_USD":2626000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":11857000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3478000.0,"OperatingIncomeLoss_2_Q2_USD":-30632000.0,"OperatingIncomeLoss_1_Q2_USD":-4049000.0,"OperatingExpenses_2_Q2_USD":57539000.0,"OperatingExpenses_1_Q2_USD":29417000.0,"NetIncomeLoss_1_Q2_USD":-4011000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1100000.0,"NetIncomeLoss_2_Q2_USD":-30546000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":6026000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":42607000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":48601000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":51212000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":83000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":363000.0,"StockIssued1_2_Q2_USD":2000.0,"StockholdersEquity_0_Q2_USD":278462000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":11.03,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.04,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":8.75,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":4680000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":9239000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":9.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7476000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":10719000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":7.63,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":6.21,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1475000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":11.58,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":222000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":2900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":100000.0,"ShareBasedCompensation_2_Q2_USD":5760000.0,"RevenueFromRelatedParties_2_Q2_USD":26907000.0,"RevenueFromRelatedParties_1_Q2_USD":25368000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-181547000.0,"RestrictedCashNoncurrent_0_Q2_USD":1300000.0,"RestrictedCash_0_Q2_USD":1270000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":22100000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-58464000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-40141000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":91926000.0,"CommonStockValue_0_Q2_USD":51000.0,"CommonStockSharesOutstanding_0_Q2_shares":51221000.0,"CommonStockSharesIssued_0_Q2_shares":51221000.0,"CommonStockSharesAuthorized_0_Q2_shares":160000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":9764000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-6679000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":142084000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":140814000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":33000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":26015000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":79319000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":30000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":6000.0,"AssetsCurrent_0_Q2_USD":257119000.0,"Assets_0_Q2_USD":306160000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7888000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":8141000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5760000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2935000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2935000.0,"AdditionalPaidInCapital_0_Q2_USD":459982000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-24000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":4973000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":9853000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-338000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-4010000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-30553000.0,"ContractWithCustomerLiability_0_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":15841000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":306160000.0,"Liabilities_0_Q2_USD":27698000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-101000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-345000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-1931000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-2232000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":24945000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":473000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":3000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":2000.0,"IncomeTaxesPaid_2_Q2_USD":8000.0,"IncomeLossAttributableToParent_2_Q2_USD":-30543000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":48601000.0,"IncomeLossAttributableToParent_1_Q2_USD":-4009000.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q2_USD":39800000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":14932000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7317000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":15600000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4453000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.08,"EarningsPerShareDiluted_2_Q2_USD":-0.63,"EarningsPerShareBasic_2_Q2_USD":-0.63,"EarningsPerShareBasic_1_Q2_USD":-0.08,"DueFromRelatedPartiesCurrent_0_Q2_USD":24976000.0,"Depreciation_2_Q2_USD":1501000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q2_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":51212000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]